190 related articles for article (PubMed ID: 27581662)
21. Identification of genomic signatures in circulating tumor cells from breast cancer.
Kanwar N; Hu P; Bedard P; Clemons M; McCready D; Done SJ
Int J Cancer; 2015 Jul; 137(2):332-44. PubMed ID: 25529931
[TBL] [Abstract][Full Text] [Related]
22. Personalized medicine: present and future of breast cancer management.
Sabatier R; Gonçalves A; Bertucci F
Crit Rev Oncol Hematol; 2014 Sep; 91(3):223-33. PubMed ID: 24725667
[TBL] [Abstract][Full Text] [Related]
23. Circulating tumor cells in breast cancer.
Banys M; Müller V; Melcher C; Aktas B; Kasimir-Bauer S; Hagenbeck C; Hartkopf A; Fehm T
Clin Chim Acta; 2013 Aug; 423():39-45. PubMed ID: 23623805
[TBL] [Abstract][Full Text] [Related]
24. Intratumor genomic heterogeneity in breast cancer with clonal divergence between primary carcinomas and lymph node metastases.
Torres L; Ribeiro FR; Pandis N; Andersen JA; Heim S; Teixeira MR
Breast Cancer Res Treat; 2007 Apr; 102(2):143-55. PubMed ID: 16906480
[TBL] [Abstract][Full Text] [Related]
25. What to expect from high throughput genomics in metastatic breast cancers?
Onesti CE; Vicier C; André F
Breast; 2015 Nov; 24 Suppl 2():S19-22. PubMed ID: 26238439
[TBL] [Abstract][Full Text] [Related]
26. Using single-cell sequencing technology to detect circulating tumor cells in solid tumors.
Xu J; Liao K; Yang X; Wu C; Wu W
Mol Cancer; 2021 Aug; 20(1):104. PubMed ID: 34412644
[TBL] [Abstract][Full Text] [Related]
27. Using circulating tumor cells to guide therapy in breast cancer: could this replace biopsies?
Dawood S; Cristofanilli M
Pharmacogenomics; 2015; 16(7):669-72. PubMed ID: 25950463
[No Abstract] [Full Text] [Related]
28. Circulating tumor cells in patients with breast cancer: monitoring chemotherapy success.
Ušiaková Z; Mikulová V; Pintérová D; Brychta M; Valchář J; Kubecová M; Tesařová P; Bobek V; Kološtová K
In Vivo; 2014; 28(4):605-14. PubMed ID: 24982230
[TBL] [Abstract][Full Text] [Related]
29. Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy.
Schlange T; Pantel K
Pharmacogenomics; 2016 Feb; 17(3):183-6. PubMed ID: 26799583
[No Abstract] [Full Text] [Related]
30. Breast cancer genome heterogeneity: a challenge to personalised medicine?
Swanton C; Burrell RA; Futreal PA
Breast Cancer Res; 2011 Feb; 13(1):104. PubMed ID: 21345264
[TBL] [Abstract][Full Text] [Related]
31. [The circulating tumor cells under breast cancer: systems of detection, molecular characteristic and issues of future studies].
Lianodou ES; Markou A
Klin Lab Diagn; 2013 Aug; (8):41-51. PubMed ID: 24340748
[No Abstract] [Full Text] [Related]
32. Advancing Cancer Research and Medicine with Single-Cell Genomics.
Lim B; Lin Y; Navin N
Cancer Cell; 2020 Apr; 37(4):456-470. PubMed ID: 32289270
[TBL] [Abstract][Full Text] [Related]
33. Medical oncology: clinical value of circulating tumor cells in breast cancer.
Sleijfer S; Foekens JA
Nat Rev Clin Oncol; 2011 Nov; 8(12):696-8. PubMed ID: 22048626
[No Abstract] [Full Text] [Related]
34. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer.
Klein CA; Blankenstein TJ; Schmidt-Kittler O; Petronio M; Polzer B; Stoecklein NH; Riethmüller G
Lancet; 2002 Aug; 360(9334):683-9. PubMed ID: 12241875
[TBL] [Abstract][Full Text] [Related]
35. Intratumor Heterogeneity: Novel Approaches for Resolving Genomic Architecture and Clonal Evolution.
Gupta RG; Somer RA
Mol Cancer Res; 2017 Sep; 15(9):1127-1137. PubMed ID: 28596419
[TBL] [Abstract][Full Text] [Related]
36. Precision Medicine in Breast Cancer.
Odle TG
Radiol Technol; 2017 Mar; 88(4):401M-421M. PubMed ID: 28298516
[TBL] [Abstract][Full Text] [Related]
37. [Molecular origins of cancer and future cancer therapy].
Xie L; Hu WJ; Liu BR
Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):81-84. PubMed ID: 29502365
[TBL] [Abstract][Full Text] [Related]
38. Longtime recirculating tumor cells in breast cancer patients.
Pachmann K
Clin Cancer Res; 2005 Aug; 11(15):5657; author reply 5657-8. PubMed ID: 16061886
[No Abstract] [Full Text] [Related]
39. Advances in Tumor Sampling and Sequencing in Breast Cancer and their Application in Precision Diagnostics and Therapeutics.
Lee AC; Lee HB; Yeom H; Song SW; Kim SD; Choi A; Lee S; Lee Y; Han W; Kwon S
Adv Exp Med Biol; 2021; 1187():215-244. PubMed ID: 33983581
[TBL] [Abstract][Full Text] [Related]
40. Biological progression of breast cancer and clinical implications.
Vici P; Sergi D; Pizzuti L; Vincenzoni C; Baiocco E; Mancini E; Lopez M; Vizza E; Lauro LD
Clin Ter; 2011; 162(4):297-9. PubMed ID: 21912815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
